← Back to Clinical Trials
Recruiting NCT07317492

NCT07317492 HEMOVAR Study on Hemorrhoids and Varicose Veins

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07317492
Status Recruiting
Phase
Sponsor Aydin Adnan Menderes University
Condition Varicose Veins of Lower Limb
Study Type OBSERVATIONAL
Enrollment 400 participants
Start Date 2025-12-19
Primary Completion 2026-11-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 400 participants in total. It began in 2025-12-19 with a primary completion date of 2026-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The HEMOVAR Study is a prospective observational study designed to evaluate the association between hemorrhoidal disease and lower extremity varicose veins. A total of 400 adult patients presenting to the general surgery proctology outpatient clinic of Aydın Adnan Menderes University Hospital will be included. The study will consist of two groups: 200 patients diagnosed with hemorrhoids and 200 patients with other non-hemorrhoidal benign proctologic conditions serving as controls. All participants will undergo routine clinical evaluation and demographic data collection. Cardiovascular surgeons will voluntarily perform physical examination and Doppler ultrasonography of the lower extremities to assess venous insufficiency and varicose veins. No experimental intervention or treatment will be applied. The study will not require any consumable materials and will not impose any additional financial burden on the hospital, patients, or the national health insurance system. The primary outcome is the prevalence of lower extremity venous insufficiency in patients with hemorrhoids compared with controls.

Eligibility Criteria

Inclusion Criteria: * Adults aged 18 years or older * Patients presenting to the general surgery proctology outpatient clinic of Aydın Adnan Menderes University Hospital * Patients diagnosed with hemorrhoidal disease or other non-hemorrhoidal benign proctologic conditions * Ability to understand the study procedures and provide written informed consent Exclusion Criteria: * Patients younger than 18 years * History of lower extremity varicose vein surgery, endovenous ablation, or sclerotherapy * Presence of systemic venous disorders such as portal hypertension or liver cirrhosis * Pregnant women * Patients with known malignancy or severe comorbid conditions that could interfere with evaluation * Refusal or inability to provide written informed consent

Contact & Investigator

Central Contact

Akay Edizsoy, MD

✉ akayedizsoy@adu.edu.tr

📞 +905066332767

Principal Investigator

Akay Edizsoy, Assist Prof.

STUDY CHAIR

Aydin Adnan Menderes University, School of Medicine

Frequently Asked Questions

Who can join the NCT07317492 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Varicose Veins of Lower Limb. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07317492 currently recruiting?

Yes, NCT07317492 is actively recruiting participants. Contact the research team at akayedizsoy@adu.edu.tr for enrollment information.

Where is the NCT07317492 trial being conducted?

This trial is being conducted at Aydin, Turkey (Türkiye).

Who is sponsoring the NCT07317492 clinical trial?

NCT07317492 is sponsored by Aydin Adnan Menderes University. The principal investigator is Akay Edizsoy, Assist Prof. at Aydin Adnan Menderes University, School of Medicine. The trial plans to enroll 400 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology